Dr. Thoennissen is a distinguished expert in evidence-based medicine with over two decades of experience, including 14 years of clinical practice in haemotherapy, blood transfusion, and stem cell transplantation. His expertise spans cancer treatment, chronic degenerative diseases, and regenerative medicine. He earned his PhD in neurological research with the highest distinction, summa cum laude.
Dr. Thoennissen’s academic journey includes studies at Westfälische Wilhelms University (Münster, Germany), Cardiff University School of Medicine (Great Britain), and Johannes Gutenberg University (Mainz, Germany), as well as advanced research at Cedars-Sinai Medical Center, UCLA (Los Angeles, USA). His specialist training and fellowships include roles in the Department of Haematology, Oncology, and Transplantation at University Hospital Münster, along with prestigious research fellowships from IZKF and the German Research Foundation (DFG) at Cedars-Sinai Medical Center.
Recognized for his contributions to medical innovation, Dr. Thoennissen has received numerous awards, including the summa cum laude distinction for his doctoral thesis, the University Hospital Münster Innovation Prize, and multiple travel awards from the American Society of Hematology (ASH). His research excellence has also been acknowledged with accolades such as the Leukaemia Research Sponsorship Award, the German Society for Digestive and Metabolic Diseases Award, and the Best of DGHO – Translational Medicine recognition for his groundbreaking work in myeloproliferative neoplasms.
Driven by a commitment to advancing medical science, Dr. Thoennissen continues to pioneer innovative therapeutic approaches that bridge cutting-edge research with clinical application.